Hamlet BioPharma is pleased to announce a recent article about human breast milk in The Economist, a leading international newspaper. The article highlights the pioneering work on HAMLET being conducted at Lund University, exploring the remarkable therapeutic properties of breast milk components in treating cancer and other diseases.

"This is important recognition of our findings and supports the relevance of our approach to developing novel cancer treatments." says Catharina Svanborg, Lund University and Hamlet BioPharma.

Read the article in The Economist here: https://www.economist.com/science-and-technology/2024/09/11/breast-milks-benefits-are-not-limited-to-babies.An account is required to be able to read the full article

For more information on the research and Hamlet BioPharma's ongoing efforts, please visit https://hamletbiopharma.com.

For further information, please contact:

Catharina Svanborg, Chairman and Founder of Hamlet BioPharma, +46-709 42 65 49

catharina.svanborg@hamletpharma.com

Martin Erixon, CEO Hamlet BioPharma, +46-733 00 43 77

martin.erixon@hamletpharma.com